ArticleCureus2025

Efficacy and Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Patients With Non-small Cell Lung Cancer and Autoimmune Diseases.

Kenta Takashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.